2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow COVID 19: new trials by email Literature Review of COVID 19 trials Research Report on COVID 19
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Stellate Ganglion Blockade in Corona Virus 2019 (COVID-19) Positive Patients Stellate Ganglion Block - COVID 19, ARDS | Phase 1 | Terminated | University of Nebraska | 1 | 2020-11-15 | 2025-01-20 |
| Anti-SARS Cov-2 T Cell Infusions for COVID 19 Dose Finding Phase (MTD), Partially HLA-matched SARS-CoVSTs, Routine care (no SARS-CoVSTs) - SARS-CoV 2, Viral Infection | Phase 1 | Terminated | Baylor College of Medicine | 4 | 2020-11-04 | 2022-12-19 |
COVID-19 (2) · Virus Diseases (1)
Coronaviridae Infections (2) · Coronavirus Infections (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Virus Diseases (1)
Calcium Dobesilate (1) · Clonidine (1) · Maximum Tolerated Dose (1)
Baylor College of Medicine (1) · University of Nebraska (1)
United States (2)
Michael Lankhorst, MD (1) · Premal Lulla (1)